Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-intensity statin vs moderate-intensity statin + ezetimibe in older patients with acute coronary syndrome
KCT0007428Phase 4Not yet recruiting
- Sponsor
- Hanmi Pharmaceutical
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in acute coronary syndrome (ACS), dyslipidemia, sponsored by Hanmi Pharmaceutical. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
ezetimibe
03
Conditions
acute coronary syndrome (ACS)dyslipidemia
Beyond the preview
Go deeper on KCT0007428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007428.